{"id":780857,"date":"2023-08-30T06:36:31","date_gmt":"2023-08-30T10:36:31","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/oculis-to-present-at-upcoming-september-investor-conferences\/"},"modified":"2023-08-30T06:36:31","modified_gmt":"2023-08-30T10:36:31","slug":"oculis-to-present-at-upcoming-september-investor-conferences","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/oculis-to-present-at-upcoming-september-investor-conferences\/","title":{"rendered":"Oculis to Present at Upcoming September Investor Conferences"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">ZUG, Switzerland, and BOSTON, Aug.  30, 2023  (GLOBE NEWSWIRE) &#8212; Oculis Holding AG (Nasdaq: OCS) (\u201cOculis\u201d), a global biopharmaceutical company purposefully driven to save sight and improve eye care, today announced that Riad Sherif, MD, Chief Executive Officer, and Sylvia Cheung, Chief Financial Officer will be attending and presenting at the following upcoming investor conferences:<\/p>\n<p align=\"justify\">\n        <strong>H.C. Wainwright 25<\/strong><br \/>\n        <sup><br \/>\n          <strong>th<\/strong><br \/>\n        <\/sup><br \/>\n        <strong> Annual Global Investment Conference<\/strong><br \/>\n        <br \/>Format: Company presentation <br \/>Presentation date and time: September 11, 2023 at 8:30 am ET<br \/>Location: New York, New York and Virtual<\/p>\n<p align=\"justify\">\n        <strong>Pareto Securities\u2019 13<\/strong><br \/>\n        <sup><br \/>\n          <strong>th<\/strong><br \/>\n        <\/sup><br \/>\n        <strong> Annual Healthcare Conference<\/strong><br \/>\n        <br \/>Format: Company presentation <br \/>Presentation date and time: September 14, 2023 at 8:10 am ET (2:10 pm CEST)<br \/>Location: Stockholm, Sweden<\/p>\n<p align=\"justify\">The Oculis management team will be available for one-on-one meetings during the conferences. Interested investors should contact their respective representative at the sponsoring institutions to request meetings. Links to access company presentation and webcast for select events, when available, will be posted to Oculis\u2019 website on the <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=BXit8vY5v6ymeHuuA4kETJttXnrRc2mzBi9vOB6i0qDgKwZU97iltSzzz0DSAbNXej4TWrFB2tE4Vr9WfKmwtYF6nM2iyzJcmmYKfplizlv-iE_Qlr9lrfVUOxczJhHVtVEGnjNfFkU0lzpwanCxSw==\" rel=\"nofollow noopener\" target=\"_blank\">Events &amp; Presentations<\/a> page of the Investors section.<\/p>\n<p>\n        <strong>About Oculis<\/strong>\n      <\/p>\n<p align=\"justify\">Oculis (Nasdaq: OCS) is a global biopharmaceutical company purposefully driven to save sight and improve eye care. Oculis\u2019s highly differentiated clinical-stage pipeline comprises multiple innovative product candidates in development for eye diseases of high unmet need. It includes OCS-01 eye drops, a topical candidate in Phase 3 development for diabetic macular edema (DME) and inflammation and pain following ocular surgery; OCS-02 eye drops, a topical biologic candidate in Phase 2 development for dry eye disease (DED) and uveitis; and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophthalmic disorders, such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis. The first in-patient, proof-of-concept trial with OCS-05 is currently ongoing in France. Headquartered in Switzerland and with operations in the US, Oculis\u2019 goal is to deliver life-changing eye treatments to patients worldwide. The company is led by an experienced management team with a successful track record in the pharmaceutical industry, supported by leading international healthcare investors.<\/p>\n<p align=\"justify\">For more information, please visit: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=RqFIBYajcERxxvd1DLILGXxj8avBIA1TRG0S-3Wvz8-TXADY2fFM_jgC7HQPL-hOutbJWGSe7lKvv9PYve_O_Q==\" rel=\"nofollow noopener\" target=\"_blank\">www.oculis.com<\/a><\/p>\n<p>\n        <strong>Oculis Contacts<\/strong>\n      <\/p>\n<p>Mrs. Sylvia Cheung, CFO<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=oL2Uy6DqqRaJnlYwcfw8gcoOBgsOrXfPlf4WjOj-jvJmeayUfhXF7SwpIIrDnVFympjujC5ZpJYn67YjKfJVKW6xzEkrj153uCTqx156VQHILneEPBoWcaAfx8FsMVgtgnaRUMDhuPq30OUUqifZbtdoMoEq9BIJ3-1VXsNXuQIZ56JGBY-9rH4pHAsD54i3rtRXJa7k6_aVHL4mZlsQv60OiDUSShtCuJwCzi6_CSQI5C9tMFHRZkuVMeKYweNhi1onOVn8jT_YbWxP2YK86g-Co3p438SNzEewIXDreuA=\" rel=\"nofollow noopener\" target=\"_blank\"><u>sylvia.cheung@oculis.com<\/u><\/a><\/p>\n<p>\n        <strong>Investor &amp; Media Relations <\/strong>\n      <\/p>\n<p>LifeSci Advisors<br \/>Corey Davis, Ph.D.<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=YvGExPWp_mM8Nc1TTHLJnXwLES76I0IKAlXT8SD6qpq6cQYrBCth1x1vNCZFrxx_J7eB_BVKAB0JXQY95trp1HqLJYUwvp8fPkWoOVtvsaJIvpQZkPZP3DrdT0SpRIXv\" rel=\"nofollow noopener\" target=\"_blank\"><u>cdavis@lifesciadvisors.com<\/u><\/a><br \/>1-212-915-2577<\/p>\n<p \/>\n      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkxMTk3NSM1Nzg2MDM5IzUwMDExNzg0OA==\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/ZGNkNDQ1MzItOGZjNy00NzJhLWFiNDYtMGVkZjFiMmFhMzVjLTUwMDExNzg0OA==\/tiny\/Oculis-Holding-AG.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>ZUG, Switzerland, and BOSTON, Aug. 30, 2023 (GLOBE NEWSWIRE) &#8212; Oculis Holding AG (Nasdaq: OCS) (\u201cOculis\u201d), a global biopharmaceutical company purposefully driven to save sight and improve eye care, today announced that Riad Sherif, MD, Chief Executive Officer, and Sylvia Cheung, Chief Financial Officer will be attending and presenting at the following upcoming investor conferences: H.C. Wainwright 25 th Annual Global Investment Conference Format: Company presentation Presentation date and time: September 11, 2023 at 8:30 am ETLocation: New York, New York and Virtual Pareto Securities\u2019 13 th Annual Healthcare Conference Format: Company presentation Presentation date and time: September 14, 2023 at 8:10 am ET (2:10 pm CEST)Location: Stockholm, Sweden The Oculis management team will be available for one-on-one meetings during &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/oculis-to-present-at-upcoming-september-investor-conferences\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Oculis to Present at Upcoming September Investor Conferences&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-780857","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Oculis to Present at Upcoming September Investor Conferences - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/oculis-to-present-at-upcoming-september-investor-conferences\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Oculis to Present at Upcoming September Investor Conferences - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"ZUG, Switzerland, and BOSTON, Aug. 30, 2023 (GLOBE NEWSWIRE) &#8212; Oculis Holding AG (Nasdaq: OCS) (\u201cOculis\u201d), a global biopharmaceutical company purposefully driven to save sight and improve eye care, today announced that Riad Sherif, MD, Chief Executive Officer, and Sylvia Cheung, Chief Financial Officer will be attending and presenting at the following upcoming investor conferences: H.C. Wainwright 25 th Annual Global Investment Conference Format: Company presentation Presentation date and time: September 11, 2023 at 8:30 am ETLocation: New York, New York and Virtual Pareto Securities\u2019 13 th Annual Healthcare Conference Format: Company presentation Presentation date and time: September 14, 2023 at 8:10 am ET (2:10 pm CEST)Location: Stockholm, Sweden The Oculis management team will be available for one-on-one meetings during &hellip; Continue reading &quot;Oculis to Present at Upcoming September Investor Conferences&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/oculis-to-present-at-upcoming-september-investor-conferences\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-08-30T10:36:31+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkxMTk3NSM1Nzg2MDM5IzUwMDExNzg0OA==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oculis-to-present-at-upcoming-september-investor-conferences\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oculis-to-present-at-upcoming-september-investor-conferences\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Oculis to Present at Upcoming September Investor Conferences\",\"datePublished\":\"2023-08-30T10:36:31+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oculis-to-present-at-upcoming-september-investor-conferences\\\/\"},\"wordCount\":356,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oculis-to-present-at-upcoming-september-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODkxMTk3NSM1Nzg2MDM5IzUwMDExNzg0OA==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oculis-to-present-at-upcoming-september-investor-conferences\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oculis-to-present-at-upcoming-september-investor-conferences\\\/\",\"name\":\"Oculis to Present at Upcoming September Investor Conferences - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oculis-to-present-at-upcoming-september-investor-conferences\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oculis-to-present-at-upcoming-september-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODkxMTk3NSM1Nzg2MDM5IzUwMDExNzg0OA==\",\"datePublished\":\"2023-08-30T10:36:31+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oculis-to-present-at-upcoming-september-investor-conferences\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oculis-to-present-at-upcoming-september-investor-conferences\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oculis-to-present-at-upcoming-september-investor-conferences\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODkxMTk3NSM1Nzg2MDM5IzUwMDExNzg0OA==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODkxMTk3NSM1Nzg2MDM5IzUwMDExNzg0OA==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oculis-to-present-at-upcoming-september-investor-conferences\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Oculis to Present at Upcoming September Investor Conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Oculis to Present at Upcoming September Investor Conferences - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/oculis-to-present-at-upcoming-september-investor-conferences\/","og_locale":"en_US","og_type":"article","og_title":"Oculis to Present at Upcoming September Investor Conferences - Market Newsdesk","og_description":"ZUG, Switzerland, and BOSTON, Aug. 30, 2023 (GLOBE NEWSWIRE) &#8212; Oculis Holding AG (Nasdaq: OCS) (\u201cOculis\u201d), a global biopharmaceutical company purposefully driven to save sight and improve eye care, today announced that Riad Sherif, MD, Chief Executive Officer, and Sylvia Cheung, Chief Financial Officer will be attending and presenting at the following upcoming investor conferences: H.C. Wainwright 25 th Annual Global Investment Conference Format: Company presentation Presentation date and time: September 11, 2023 at 8:30 am ETLocation: New York, New York and Virtual Pareto Securities\u2019 13 th Annual Healthcare Conference Format: Company presentation Presentation date and time: September 14, 2023 at 8:10 am ET (2:10 pm CEST)Location: Stockholm, Sweden The Oculis management team will be available for one-on-one meetings during &hellip; Continue reading \"Oculis to Present at Upcoming September Investor Conferences\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/oculis-to-present-at-upcoming-september-investor-conferences\/","og_site_name":"Market Newsdesk","article_published_time":"2023-08-30T10:36:31+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkxMTk3NSM1Nzg2MDM5IzUwMDExNzg0OA==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/oculis-to-present-at-upcoming-september-investor-conferences\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/oculis-to-present-at-upcoming-september-investor-conferences\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Oculis to Present at Upcoming September Investor Conferences","datePublished":"2023-08-30T10:36:31+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/oculis-to-present-at-upcoming-september-investor-conferences\/"},"wordCount":356,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/oculis-to-present-at-upcoming-september-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkxMTk3NSM1Nzg2MDM5IzUwMDExNzg0OA==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/oculis-to-present-at-upcoming-september-investor-conferences\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/oculis-to-present-at-upcoming-september-investor-conferences\/","name":"Oculis to Present at Upcoming September Investor Conferences - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/oculis-to-present-at-upcoming-september-investor-conferences\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/oculis-to-present-at-upcoming-september-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkxMTk3NSM1Nzg2MDM5IzUwMDExNzg0OA==","datePublished":"2023-08-30T10:36:31+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/oculis-to-present-at-upcoming-september-investor-conferences\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/oculis-to-present-at-upcoming-september-investor-conferences\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/oculis-to-present-at-upcoming-september-investor-conferences\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkxMTk3NSM1Nzg2MDM5IzUwMDExNzg0OA==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkxMTk3NSM1Nzg2MDM5IzUwMDExNzg0OA=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/oculis-to-present-at-upcoming-september-investor-conferences\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Oculis to Present at Upcoming September Investor Conferences"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/780857","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=780857"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/780857\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=780857"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=780857"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=780857"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}